Clinical Trials
2 trialsNCT02971761 2024-02-20
Pembrolizumab and Enobosarm in Treating Patients With Androgen Receptor Positive Metastatic Triple Negative Breast Cancer
City of Hope Medical Center
Phase 2 Completed
NCT02463032 2020-12-09
Efficacy and Safety of GTx-024 in Patients With Estrogen Receptor (ER)+/Androgen Receptor (AR)+ Breast Cancer
GTx
Phase 2 Completed